Anna T Prescott1, Jay G Hull1, J Nicholas Dionne-Odom2, Tor D Tosteson3, Kathleen Doyle Lyons4, Zhigang Li5, Zhongze Li3, Konstantin H Dragnev6, Mark T Hegel4, Karen E Steinhauser7, Tim A Ahles8, Marie A Bakitas9. 1. Department of Psychological and Brain Sciences, Dartmouth College. 2. School of Nursing, University of Alabama at Birmingham. 3. Biostatistics Shared Resource, Norris Cotton Cancer Center. 4. Department of Psychiatry, Geisel School of Medicine at Dartmouth. 5. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth. 6. Department of Medicine, Section of Hematology/Oncology, Dartmouth-Hitchcock Medical Center. 7. Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center. 8. Department of Psychiatry, Memorial Sloan-Kettering Cancer Center. 9. School of Nursing and Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham.
Abstract
OBJECTIVE: Randomized controlled trials (RCTs) of early palliative care interventions in advanced cancer have positively impacted patient survival, yet the mechanisms remain unknown. This secondary analysis of 2 RCTs assessed whether an early palliative care intervention moderates the relationship between depressive symptoms and survival. METHOD: The relationships among mood, survival, and early palliative care intervention were studied among 529 advanced cancer patients who participated in 2 RCTs. The first (N = 322) compared intervention versus usual care. The second (N = 207) compared early versus delayed intervention (12 weeks after enrollment). The interventions included an in-person consultation, weekly nurse coach-facilitated phone sessions, and monthly follow-up. Mood was measured using the Center for Epidemiologic Studies-Depression (CES-D) scale. Cox proportional hazard analyses were used to examine the effects of baseline CES-D scores, the intervention, and their interaction on mortality risk while controlling for demographic variables, cancer site, and illness severity. RESULTS: The combined sample was 56% male (M = 64.7 years). Higher baseline CES-D scores were significantly associated with greater mortality risk (hazard ratio [HR] = 1.042, 95% confidence interval [CI] [1.017, 1.067], p = .001). However, participants with higher CES-D scores who received the intervention had a lower mortality risk (HR = .963, CI [0.933, 0.993], p = .018) even when controlling for demographics, cancer site, and illness-related variables. CONCLUSION: This study is the first to demonstrate that patients with advanced cancer who also have depressive symptoms benefit the most from early palliative care. Future research should be devoted to exploring the mechanisms responsible for these relationships. (PsycINFO Database Record (c) 2017 APA, all rights reserved).
OBJECTIVE: Randomized controlled trials (RCTs) of early palliative care interventions in advanced cancer have positively impacted patient survival, yet the mechanisms remain unknown. This secondary analysis of 2 RCTs assessed whether an early palliative care intervention moderates the relationship between depressive symptoms and survival. METHOD: The relationships among mood, survival, and early palliative care intervention were studied among 529 advanced cancerpatients who participated in 2 RCTs. The first (N = 322) compared intervention versus usual care. The second (N = 207) compared early versus delayed intervention (12 weeks after enrollment). The interventions included an in-person consultation, weekly nurse coach-facilitated phone sessions, and monthly follow-up. Mood was measured using the Center for Epidemiologic Studies-Depression (CES-D) scale. Cox proportional hazard analyses were used to examine the effects of baseline CES-D scores, the intervention, and their interaction on mortality risk while controlling for demographic variables, cancer site, and illness severity. RESULTS: The combined sample was 56% male (M = 64.7 years). Higher baseline CES-D scores were significantly associated with greater mortality risk (hazard ratio [HR] = 1.042, 95% confidence interval [CI] [1.017, 1.067], p = .001). However, participants with higher CES-D scores who received the intervention had a lower mortality risk (HR = .963, CI [0.933, 0.993], p = .018) even when controlling for demographics, cancer site, and illness-related variables. CONCLUSION: This study is the first to demonstrate that patients with advanced cancer who also have depressive symptoms benefit the most from early palliative care. Future research should be devoted to exploring the mechanisms responsible for these relationships. (PsycINFO Database Record (c) 2017 APA, all rights reserved).
Authors: William F Pirl; Joseph A Greer; Lara Traeger; Vicki Jackson; Inga T Lennes; Emily R Gallagher; Pedro Perez-Cruz; Rebecca S Heist; Jennifer S Temel Journal: J Clin Oncol Date: 2012-03-19 Impact factor: 44.544
Authors: Marianna Kyranou; Kathleen Puntillo; Bradley E Aouizerat; Laura B Dunn; Steven M Paul; Bruce A Cooper; Claudia West; Marylin Dodd; Charles Elboim; Christine Miaskowski Journal: J Appl Biobehav Res Date: 2014-06
Authors: Marie A Bakitas; Tor D Tosteson; Zhigang Li; Kathleen D Lyons; Jay G Hull; Zhongze Li; J Nicholas Dionne-Odom; Jennifer Frost; Konstantin H Dragnev; Mark T Hegel; Andres Azuero; Tim A Ahles Journal: J Clin Oncol Date: 2015-03-23 Impact factor: 44.544
Authors: Pim Cuijpers; Nicole Vogelzangs; Jos Twisk; Annet Kleiboer; Juan Li; Brenda W Penninx Journal: Am J Psychiatry Date: 2014-04 Impact factor: 18.112
Authors: J Nicholas Dionne-Odom; Alan Kono; Jennifer Frost; Lisa Jackson; Daphne Ellis; Ali Ahmed; Andres Azuero; Marie Bakitas Journal: J Palliat Med Date: 2014-07-29 Impact factor: 2.947
Authors: Marie A Bakitas; J Nicholas Dionne-Odom; Deborah B Ejem; Rachel Wells; Andres Azuero; Macy L Stockdill; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Sally Engler; Karen Steinhauser; Elizabeth Kvale; Raegan W Durant; Rodney O Tucker; Kathryn L Burgio; Jose Tallaj; Keith M Swetz; Salpy V Pamboukian Journal: JAMA Intern Med Date: 2020-09-01 Impact factor: 21.873
Authors: Diane E Holland; Catherine E Vanderboom; Jay Mandrekar; Bijan J Borah; Ann Marie Dose; Cory J Ingram; Joan M Griffin Journal: Trials Date: 2020-10-28 Impact factor: 2.279